<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02298621</url>
  </required_header>
  <id_info>
    <org_study_id>1175</org_study_id>
    <nct_id>NCT02298621</nct_id>
  </id_info>
  <brief_title>Pomegranate Juice and Metabolic Syndrome</brief_title>
  <official_title>The Effect of Pomegranate Juice Intake on Cardiometabolic Factors in Subjects With Metabolic Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Urmia University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Urmia University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic
      syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic
      syndrome in shabestar.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in values of metabolic syndrome components at 1 week</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in values of insulin resistance (HOMA-IR), total cholesterol, LDL-C, VLDL-C and hs-CRP at 1 week</measure>
    <time_frame>1 weeks</time_frame>
    <description>Insulin resistance via HOMA-IR</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>pomegranate juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pomegranate juice: 500 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sugar + aroma+ color: 500ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pomegranate juice</intervention_name>
    <description>Randomized clinical trial or RCT</description>
    <arm_group_label>pomegranate juice</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Randomized clinical trial or RCT</description>
    <arm_group_label>pomegranate juice</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of â‰¥3 of the following diagnostic of MetS:

               -  serum TGs of at least 150 mg/dL,

               -  waist circumference of more than 102 cm (40 in) in men and more than 88 cm (35
                  in) in women,

               -  high-density lipoprotein (HDL) level less than 40 mg/dL in men and less than 50
                  mg/dL in women,

               -  blood pressure 135/85 mm Hg or higher, or

               -  fasting glucose 100 mg/dL or Higher

        Exclusion Criteria:

          -  liver cirrhosis,

          -  chronic pancreatitis,

          -  gastrointestinal or connective diseases,

          -  kidney stones, or

          -  renal failure,

          -  alcohol Consumption,

          -  having an allergy to pomegranate juice,

          -  a change in diet,

          -  the large increase in LDL so that required drug treatment.

          -  use of statins of fibrates, corticosteroids, nitrates, acetyl-salicylic acid or other
             anti-platelet drugs, oral hypoglycemic drugs, nonsteroidal anti-inflammatory drugs, or
             drugs interfering with coagulation;

          -  pregnancy or lactation in the past 6 mo, supplementation with vitamins or antioxidants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohammad alizadeh</last_name>
    <role>Study Director</role>
    <affiliation>Urmia University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urmia University of Medical Sciences</name>
      <address>
        <city>Urmia</city>
        <zip>+98</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>November 19, 2014</last_update_submitted>
  <last_update_submitted_qc>November 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

